In response to rising health spending, public and private insurers use two mechanisms to direct spending toward more valuable treatments: “demand-side” incentives, which impose costs on the patient to limit moral hazard, and “supply-side” incentives, which adjust the physician’s compensation to discourage spending. Using variation in patients’ and physicians’ exposure to incentives, I identify ...